Thorax

Article	Citations
Donor lung allocation scheme: how can we measure success?	218
Type-2 inflammation: a key treatable trait associated with lung function decline in chronic airways disease	185
Influence of age on clinical characteristics, pharmacological management and exacerbations in children with asthma	161
Beware, vaping e-cigarettes around children is adversely impacting their lung health	143
Environmental exposures associated with early childhood recurrent wheezing in the mother and child in the environment birth cohort: a time-to-event study	133
Strengthening the evidence base to support stronger regulation of social media based advertising of e-cigarette products to youth	108
New path for understanding mucociliary clearance	96
Multiple intrathoracic extramedullary haematopoiesis as visualised on medical thoracoscopy	91
To progress or not to progress: new insights into the evolution of pleuropulmonary blastomas come from studying lung cysts in adolescents and adults withDICER1-related tumour predisposition	85
Ablation for lung cancer: hot or cold intervention	77
Relationship between cumulative silica exposure and silicosis: a systematic review and dose-response meta-analysis	75
Availability, cost and affordability of essential medicines for chronic respiratory diseases in low-income and middle-income countries: a cross-sectional study	73
Genesis of concurrent diseases: do diabetes mellitus and idiopathic pulmonary fibrosis have a direct relationship?	68
Neuropsychiatric diagnoses after montelukast initiation in paediatric patients with asthma	66
Journal club	65
Combining clinical, radiological and genetic approaches to pneumothorax management	63
Smoking and COVID-19 outcomes: an observational and Mendelian randomisation study using the UK Biobank cohort	59
Association between time-to-treatment and outcomes in non-small cell lung cancer: a systematic review	59
Highlights from this issue	55
Journal club	53
Journal club	53
Cardiovascular outcomes in obstructive sleep apnoea and implications of clinical phenotyping on effect of CPAP treatment	49
Use of inhaled corticosteroids and the risk of hospitalisation for pneumonia in children with asthma: a nationwide cohort study	47
Highlights from this issue	47
Incidence, treatment and survival of malignant pleural and peritoneal mesothelioma: a population-based study	45

Nasal versus oronasal masks for home non-invasive ventilation in patients with chronic hypercapnia: a systematic review and individual participant data meta-analysis	45
Circulating cell-free double-stranded DNA and metabolic derangements in idiopathic pulmonary fibrosis: a new association	44
Long-term effect of asthma on the development of obesity among adults: an international cohort study, ECRHS	44
Blowing hot and cold over asthma hospitalisations	41
Lung allocation: a vexed, complex multifaceted challenge	41
E-cigarette use in young adults and adolescents: not so safe?	41
ATP binding cassette member A3 (ABCA3): coming of age	40
Nationwide indoor smoking ban and impact on smoking behaviour and lung function: a two-population natural experiment	39
Height and bone mineral content after inhaled corticosteroid use in the first 6 years of life	38
Apples to apples? Comparative analyses of national CF registries	35
Identifying a hyperinflammatory subphenotype of ARDS associated with worse outcomes: may ferritin help?	35
COVID-19-related changes in outpatient CPAP setup pathways for OSA are linked with decreased 30-day CPAP usage	34
Vectura and Philip Morris: the leopard has not changed its spots	34
Admixture mapping of severe asthma exacerbations in Hispanic/Latino children and youth	34
Rectal organoid morphometric analysis (ROMA)—re: optimising measurements automatically	33
Case-based discussion: neonates on extracorporeal membrane oxygenation for undiagnosed recalcitrant pulmonary hypertension—management challenges	33
When is an AVM not an AVM?	32
Journal club	31
Angiosarcoma of the pulmonary artery as an unexpected evolution of an apparent pulmonary thromboembolism	31
Epidemiology of childhood interstitial lung disease in France: the RespiRare cohort	31
TB PCR in BAL and EBUS-TBNA samples for the diagnosis of pulmonary and mediastinal lymph node TB: retrospective TRiBE study	31
Air pollution and chronic bronchitis: the evidence firms up	30
The microbiome in IPF: tissue is not the issue	30
Rapidly progressive interstitial lung disease complicated by pulmonary interstitial emphysema in anti-MDA5 amyotrophic dermatomyositis	29
Role of the IL-33/ST2 axis in cigarette smoke-induced airways remodelling in chronic obstructive pulmonary disease	29
Massive thymoma mimicking a pleural mass	29
Lung cancer screening in advanced chronic obstructive pulmonary disease: helpful or harmful?	29
Genetic and T2 biomarkers linked to the efficacy of HDM sublingual immunotherapy in asthma	29
COP27 climate change conference: urgent action needed for Africa and the world	28
High-flow nasal oxygen: benefits are hard to show in COVID-19 patients with mild hypoxaemia	28
Journal club	28
Journal club	28
Glucagon-like peptide-1 receptor agonists may benefit cardiopulmonary outcomes in patients with COPD	27
Twenty-year-old patient with polyarthritis since childhood showing cysts and ground glass attenuation on HRCT	27
Journal club	27
Emulated trial investigating effects of multiple treatments: estimating combined effects of mucoactive nebulisers in cystic fibrosis using registry data	27
Aerosol emission from the respiratory tract: an analysis of aerosol generation from oxygen delivery systems	27
Symptom-related screening programme for early detection of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: the SYSPPE study	27
Refractory granulomatous Pneumocystis jirovecii pneumonia masquerading as malignancy	27
Budesonide/formoterol maintenance and reliever therapy versus fluticasone/salmeterol fixed-dose treatment in patients with COPD	27
Time to treat the climate and nature crisis as one indivisible global health emergency	27
Improved pulmonary function and exercise tolerance despite persistent pulmonary fibrosis over 1 year after severe COVID-19 infection	26
Reversible bronchiectasis	26
Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol	26
Improved childhood asthma control after exposure reduction interventions for desert dust and anthropogenic air pollution: the MEDEA randomised controlled trial	26
Effects of tobacco smoking on recurrent hospitalisation with pneumonia: a population-based cohort study	26
Pulmonary arteriovenous malformations may be the only clinical criterion present in genetically confirmed hereditary haemorrhagic telangiectasia	26
Fibrosing mediastinitis: ‘haemoptysis in the Heartland’	25
Secondhand nicotine vaping at home and respiratory symptoms in young adults	25
Vaping and CBD: can new technology overcome old problems?	25

Journal club	25
Can we design better ARDS trials?	25
Journal club	25
Unlocking the secrets of long non-coding RNAs in asthma	24
Bronchial gene expression signature associated with rate of subsequent FEV1 decline in individuals with and at risk of COPD	24
Use of inhaled treprostinil in patients with interstitial lung disease and pulmonary hypertension: to boldly go where no other pulmonary vasodilator has gone before?	24
Empyema necessitans secondary to bronchial stenting	24
Untargeted Molecular Analysis of Exhaled Breath as a Diagnostic Test for Ventilator-Associated Lower Respiratory Tract Infections (BreathDx)	23
Pulmonary telerehabilitation vs. conventional pulmonary rehabilitation – a secondary responder analysis	23
Loss of immune homeostasis in patients with idiopathic pulmonary arterial hypertension	23
Smartphone application-based pulmonary rehabilitation in COPD: a multicentre randomised controlled trial	22
External validation of the QCovid risk prediction algorithm for risk of COVID-19 hospitalisation and mortality in adults: national validation cohort study in Scotland	22
Ambient heat exposure and COPD hospitalisations in England: a nationwide case-crossover study during 2007–2018	22
In vivo bronchial epithelial interferon responses are augmented in asthma on day 4 following experimental rhinovirus infection	22
Tobacco use: a smoking gun for IPF?	22
Advanced MicroRNA delivery for lung inflammatory therapy: surfactant protein A controls cellular internalisation and degradation of extracellular vesicles	22
Corticosteroid therapy for treating acute exacerbation of interstitial lung diseases: a systematic review	22
Children’s charter for lung health	21
Comparative accuracy and cost-effectiveness of dynamic contrast-enhanced CT and positron emission tomography in the characterisation of solitary pulmonary nodules	21
Shift work is associated with positive COVID-19 status in hospitalised patients	20
Asthma exacerbations are associated with a decline in lung function: a longitudinal population-based study	20
Pulmonary fibrosis screening: quantifying the psychological impact	20
Acute haemoptysis, fever and abdominal pain in an adolescent from northern Australia	20
Automatic oxygen titration versus constant oxygen flow rates during walking in COPD: a randomised controlled, double-blind, crossover trial	19
Lung epithelial cells interact with immune cells and bacteria to shape the microenvironment in tuberculosis	19
Effects of non-invasive ventilation on sleep in chronic hypercapnic respiratory failure	19
Effect modification of greenness on PM2.5associated all-cause mortality in a multidrug-resistant tuberculosis cohort	19
Physical activity and body mass related to catch-up lung function growth in childhood: a population-based accelerated cohort study	19
Pulmonary emphysema subtypes defined by unsupervised machine learning on CT scans	18
Evolutive diaphragmatic lesions causing recurrent catamenial pneumothorax	18
Super-responders to anti-IL-5/anti-IL-5R are characterised by high sputum eosinophil counts at baseline	18
Ultra-low-dose CT versus chest X-ray for patients suspected of pulmonary disease at the emergency department: a multicentre randomised clinical trial	18
British Thoracic Society Guideline for pleural disease	18
Bacterial biofilms predominate in both acute and chronic human lung infections	18
Clinical implications of airway obstruction with normal or low FEV1in childhood and adolescence	18
Software using artificial intelligence for nodule and cancer detection in CT lung cancer screening: systematic review of test accuracy studies	18
Inhibition of PDIA3 in club cells attenuates osteopontin production and lung fibrosis	18
Laryngeal widening and adequate ventilation by expiratory pressure load training improve aerobic capacity in COPD: a randomised controlled trial	17
The relationship between interstitial lung abnormalities, mortality, and multimorbidity: a cohort study	17
Maternal asthma is associated with reduced lung function in male infants in a combined analysis of the BLT and BILD cohorts	17
Epidemiology and prognostic factors of pleural empyema	17
Lung cancer screening provides an opportunity for early diagnosis and treatment of interstitial lung disease	17
Time to get serious about the detection and monitoring of early lung disease in cystic fibrosis	17
Diagnostic sensitivity of pleural fluid cytology in malignant pleural effusions: systematic review and meta-analysis	17
Readmission following hospital admission for community-acquired pneumonia in England	17
Subtyping emphysematous COPD by respiratory volume change distributions on CT	17
Sleep-disordered breathing and ventilatory chemosensitivity in first ischaemic stroke patients: a prospective cohort study	16
Inhaled pirfenidone solution (AP01) for IPF: a randomised, open-label, dose–response trial	16
COVID-19 vaccine-related interstitial lung disease: a case study	16
Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score	16
A prospective longitudinal study of chronic pulmonary aspergillosis in pulmonary tuberculosis in Indonesia (APICAL)	16
Impact of lung function on cardiovascular diseases and cardiovascular risk factors: a two sample bidirectional Mendelian randomisation study	16
Predictive value of lung function measures for cardiovascular risk: a large prospective cohort study	16
Correction: Association of asthma severity and educational attainment at age 6–7 years in a birth cohort: population-based record-linkage study	15
Effects of enhanced recovery after surgery plus pulmonary rehabilitation on complications after video-assisted lung cancer surgery: a multicentre randomised controlled trial	15
ICU mobility and improved outcomes: still searching for the Holy Grail	15
Role of inflammasomes in acute respiratory distress syndrome	15
Collagen neoepitopes in sarcoidosis: what do they tell us?	15
British Thoracic Society Clinical Statement on chronic cough in adults	15
Vitamin D and bacterial pneumonias: the question of causality	15
Journal club	15
Correction:British Thoracic Society Winter Meeting 2023	15
Assessing causal relationships between diabetes mellitus and idiopathic pulmonary fibrosis: a Mendelian randomisation study	15
Correction: British Thoracic Society Winter Meeting February 2021	15
Task shifting: a common-sense approach in children with asthma?	15
Cause or consequence in idiopathic pulmonary fibrosis: using genetic data to back the right horse	14
Breathlessness across generations: results from the RHINESSA generation study	14
Journal club	14
Randomised controlled trial to investigate the use of high-frequency airway oscillations astraining toimprovedyspnoea (TIDe) in COPD	14
Impact of post-COVID-19 condition on health status and activities of daily living: the PRIME post-COVID study	14
Risk of hypersensitivity pneumonitis and other interstitial lung diseases following organic dust exposure	14
Altered purine metabolism at reperfusion affects clinical outcome in lung transplantation	14
Diffuse hyperdense micronodular airspace opacities in pulmonary alveolar microlithiasis	14
Highlights from this issue	14
Journal club	14
More thanMycobacterium tuberculosis:site-of-disease microbial communities, and their functional and clinical profiles in tuberculous lymphadenitis	14
Risk of drug-induced interstitial lung disease in hospitalised patients: a nested case–control study	14
Increasing respiratory burden of prematurity: can we turn the tide?	14
Journal club	14
Pulmonary vascular proliferation in patients with severe COVID-19: an autopsy study	14

Automatic analysis of bronchus-artery dimensions to diagnose and monitor airways disease in cystic fibrosis	13
Journal club	13
Lifetime occupational exposures and chronic obstructive pulmonary disease risk in the UK Biobank cohort	13
Haemoptysis with a Danish connection	13
Bronchiectasis severity correlates with outcome in patients with primary antibody deficiency	13
Paediatric asthma hospitalisations continue to decrease in Finland and Sweden between 2015 and 2020	13
Survival after inpatient or outpatient pulmonary rehabilitation in patients with fibrotic interstitial lung disease: a multicentre retrospective cohort study	13
Drugs without benefits? Confronting the challenges of drug-induced interstitial lung disease	13
Telephone risk-based eligibility assessment for low-dose CT lung cancer screening	13
A rare condition masquerading as lung cancer	13
Epigenome-wide association study of lung cancer among never smokers in two prospective cohorts in Shanghai, China	13
Quality of life in patients with slowly progressive neuromuscular disorders dependent on mechanical ventilation	13
COVID-19 hospital activity and in-hospital mortality during the first and second waves of the pandemic in England: an observational study	13
Growing small solid nodules in lung cancer screening: safety and efficacy of a 200 mm3minimum size threshold for multidisciplinary team referral	13
Remote vision-based digital patient monitoring of pulse and respiratory rates in acute medical wards	13
Serum proteomic profiling of rheumatoid arthritis–interstitial lung disease with a comparison to idiopathic pulmonary fibrosis	12
Opportunistic actinomycosis in pulmonary alveolar proteinosis	12
Respiratory symptoms and lung function in patients treated for pulmonary tuberculosis in Malawi: a prospective cohort study	12
Highlights from this issue	12
Neutrophil responses to RSV infection show differences between infant and adult neutrophils	12
Limited side effects of asthma treatment on growth and bone health in children	12
Airflow obstruction, impaired lung function and risk of sudden cardiac death: a prospective cohort study	12
A rare cause of an 18F-FDG positron emission tomography-positive lung lesion: look for what was lost…	12
Timing ofMycobacterium tuberculosisexposure explains variation in BCG effectiveness: a systematic review and meta-analysis	12
Integrated disease management: good news but more work to do	12
Repeatability and sensitivity to change of non-invasive end points in PAH: the RESPIRE study	12
’Pulmonary tuberculosis presenting as massive spontaneous pneumomediastinum and subcutaneous emphysema’	11
COPD in Africa: risk factors, hospitalisation, readmission and associated outcomes—a systematic review and meta-analysis	11
Phenotypic and genetically predicted leucocyte telomere length and lung cancer risk in the prospective UK Biobank	11
Getting the best from pulmonary rehabilitation	11
Consolidation with pseudocavitation	11
Extreme prematurity and adult respiratory disease	11
Lower airway microbiota in COPD and healthy controls	11
Relationship between impaired BMP signalling and clinical risk factors at early-stage vascular injury in the preterm infant	11
Outcomes from a national screening program for Ukrainian refugees at risk of drug resistant tuberculosis in Wales	11
Highlights from this issue	11
Call for emergency action to limit global temperature increases, restore biodiversity and protect health	11
Pirfenidone in fibrotic hypersensitivity pneumonitis: is it ready for prime time?	11
Hospitalised older adults with community-acquired pneumonia and sepsis have dysregulated neutrophil function but preserved glycolysis	11
Community-based approaches to improve tuberculosis services: observations from preintervention and postintervention surveys in a high TB burden disadvantaged community in India	10
Healthcare resource utilisation and medical costs for children with interstitial lung diseases (chILD) in Europe	10
BTS clinical statement for the assessment and management of respiratory problems in athletic individuals	10
Comparative estimate of glucose-lowering therapies on risk of incident pneumonia and severe sepsis: an analysis of real-world cohort data	10
High-flow nasal cannula oxygen therapy for outpatients undergoing flexible bronchoscopy: a randomised controlled trial	10
Integrative analyses for the identification of idiopathic pulmonary fibrosis-associated genes and shared loci with other diseases	10
Impact of COVID-19 national lockdown on asthma exacerbations: interrupted time-series analysis of English primary care data	10
Life’s Essential 8 and risks of mortality and cardiovascular morbidity in individuals with PRISm and its associations with transition trajectories of PRISm	10
Childhood Interstitial Lung Disease (chILD): shining a new light on childhood!	10
RAND appropriateness panel to determine the applicability of UK guidelines on the management of acute respiratory distress syndrome (ARDS) and other strategies in the context of the COVID-19 pandemic	10
Prognostic significance of radiological pleuroparenchymal fibroelastosis inMycobacterium aviumcomplex lung disease: a multicentre retrospective cohort study	10
Journal club	10
Integrated stop smoking interventions are essential to maximise the health benefits from lung cancer screening	9
Identification of molecular subphenotypes in two cohorts of paediatric ARDS	9
TRPC6 inhibitor (BI 764198) to reduce risk and severity of ARDS due to COVID-19: a phase II randomised controlled trial	9
Acute hypoxaemic respiratory failure after treatment with lower tidal volume ventilation facilitated by extracorporeal carbon dioxide removal: long-term outcomes from the REST randomised trial	9
Lung function as independent predictor of cardiovascular disease risk: implications for practice and policy	9
Association between vitamin D status at 3 years and eosinophilic asthma in 6-year-old children with a history of severe bronchiolitis	9
Lung directed antibody gene transfer confers protection against SARS-CoV-2 infection	9
Towards an integrated clinical network of care for children with sleep disordered breathing	9
Journal club	9
Tracheostomy in children is associated with neutrophilic airway inflammation	9
From bronchiolitis endotyping to asthma risk assessment	9
‘Double-bifurcated’ stent: when 3D is not an option	9
Transient visual loss following CT-guided percutaneous core needle biopsy of a lung lesion	9